EDC pushes trial reporting to real time

More than half of new clinical trials are expected to use electronic data capture technology this year, says Martin Young, VP for corporate development at Phase Forward. He notes in a Life Science Leader roundtable discussion that the Internet's "decoupling of EDC from hardware" is a big factor in the technology's acceptance.

And its purpose, according to Andrew Schachter, president and CEO at Axiom, is to facilitate real-time clinical research. Access to tools that show trial status and metrics are essential to the real-time transactional data required.

Among EDC systems, best-of-breed solutions have bested single-source systems, in part because in most cases the systems have multiple users, says Patrick Hughes, senior VP at GxP Consulting.

- here's the article

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.